Collegium Pharmaceutical Inc Logo Image

Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Collegium Pharmaceutical Inc

201-500 Employees
Based in Canton, Massachusetts

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication.

Ticker:
COLL
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drugs - Generic (See More Drugs - Generic Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol

Filter by: